AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus
Treatment Strategy Doubles Efficacy In HIV Coinfected Patients
November 19th, 2001
Daily administration of interferon alfa-2b in combination with ribavirin for the treatment of the hepatitis C virus (HCV) is more than twice as effective as the standard treatment regimen (three injections interferon/week plus ribavirin) at suppressing hepatitis C viral levels in patients coinfected with HIV, according to study results presented at the Infectious Diseases Society of America (IDSA) annual meeting in October 2001. Since the advent of highly effective HIV therapy, several recently published studies confirm that liver damage related to the hepatitis C virus is now among the leading causes of death among HIV infected persons in the United States. Nearly...
Source: AIDS Weekly (2001-11-19)
|
